Pharmacovigilance, also known as drug safety, is the pharmacological science relating to the collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical products.
Pharmacovigilance is one of the most important aspects of a clinical trial, therefore, we are committed to offering pharmacovigilance services, to monitor, assess and report on the safety of investigational and approved products to detect any change in their risk benefit profile.
We work closely with sponsors, sites, and regulators to ensure compliance against all relevant reporting requirements. We provide this service, ensuring that all identified medical journals and government publications are reviewed to identify serious or adverse events (S/AEs) and trends to be reported in due time.
At Clinique research, we follow some basic steps of pharmacovigilance processes
A Serious Adverse event (SAE) could occur during clinical trials or be suddenly reported by a patient or doctor. Unexpected adverse events can occur at any stage in the life of a product. At Clinique Research, we gather safety data throughout the life of a product using the latest software to collect and verify this information and make a timely report to the authorities.
We have expert pharmacovigilance associates that manage, observe, and report regular pharmacovigilance development and also supervise the process related to ensuring drug effectiveness and avoiding adverse or side effects of these products.